2019-001189-14: A study to explore the safety and efficacy of bimiralisib applied to the skin in patients with an inflammatory skin condition |
|
|
| Not yet recruiting | 2 | 36 | Europe | Topical bimiralisib gel, Daivobet, Daivonex, PQR309, Gel, Ointment, Daivobet, Daivonex | PIQUR Therapeutics AG, PIQUR Therapeutics AG | inflammatory and hyperproliferative skin condition, inflammatory skin condition, Diseases [C] - Immune System Diseases [C20] | | | | |